Press Releases from Protagen AG (9 total)
Protagen and Charles River form strategic partnership
Dortmund, Germany, October 28, 2011. Protagen AG, Dortmund, a GMP-certified specialist in the characterization of protein drugs and Charles River Laboratories International, Inc., one of…
Protagen and OncoTyrol form strategic alliance to validate the UNIarray® techno …
Dortmund, Germany and New Jersey, USA, June 10, 2009. Protagen AG and the Medical University Innsbruck, Department of Urology, have recently identified autoantigen candidates…
Protagen meets with FDA
Dortmund, Germany and New Jersey, USA, February 19, 2009. Protagen AG, a leading provider of GMP compliant protein analytical services, protein bioinformatics, and protein biochips…
Bayer HealthCare and Protagen sign a contract to evaluate the UNIarray® technol …
Dortmund, Germany and New Jersey, USA, December 3, 2008. Protagen AG announces the closing of a cooperation contract with Bayer HealthCare AG, Leverkusen, Germany, about…
Winner Consortium “NeuroAllianz” in the BioPharma Competition counts on UNIa …
Dortmund, Germany and New Jersey, USA, October 9, 2008: Protagen AG, a leading provider of GMP compliant protein analytical services, protein bioinformatics, and protein biochips…
Protagen closes new round of financing to strengthen technology position for nov …
Dortmund, Germany and New Jersey, USA, August 1, 2008: Protagen AG, a leading provider of GMP compliant protein analytical services, protein bioinformatics, and protein biochips…
Protagen and GeneBio Sign Distribution Agreement for Modiro®
Dortmund, Germany and Geneva, Switzerland – May 29, 2008 - Protagen AG and Geneva Bioinformatics (GeneBio) SA today announced a distribution agreement that allows GeneBio…
UNIchip protein biochips from Protagen identify significant off-target binding f …
Findings could explain side effects seen with these biological drugs for treating rheumatic diseases
Dortmund, Germany and New Jersey USA, 31 March 2008: Tumor Necrosis Factor…
direct/ Protagen AG closes second round of financing with old and new investors
The MIG AG Funds 1 and 3 in Munich are investing into Protagen AG. In cooperation with the co-investor S-Venture Capital Dortmund GmbH, Euro 3,3…
Go To Page:
